Active, Not Recruiting
The BARCODE 2 Study - The Use of Genetic Profiling to Guide Prostate Cancer Treatment
NCT02955082
- Conditions
- Hormone Refractory Prostate Cancer
- Locations
-
- Institute of Cancer Research and Royal Marsden Hospital Sutton, Surrey, United Kingdom